Rocket Lab’s $266 Million Space Force Deal Ignites a Sector-Wide Rebound
Published on 07/22/2026 at 14:31 | Redaktion boerse-global.de
The space sector found its footing on Tuesday, and Rocket Lab was leading the charge. The stock closed the regular session up 5.14% at $69.12, but the real fireworks came after the bell when the US Space Force dropped a $266 million fixed-price contract for suborbital launch services. Shares surged as much as 9% in after-hours trading, briefly touching $73.19.
The rally wasn’t confined to Rocket Lab. AST SpaceMobile jumped 12%, SpaceX-related equities climbed 7%, and Virgin Galactic added 6% — a broad recovery after weeks of selling pressure across the space industry. For Rocket Lab, the move came without any company-specific news during regular hours, though analysts increasingly point to its vertically integrated model as a template for rivals seeking tighter control over costs and launch schedules.
A Contract With Teeth
The Space Systems Command at Kirtland Air Force Base in New Mexico awarded the firm-fixed-price contract, which covers 12 suborbital launches with options for six additional missions. Work will be conducted at the Pacific Spaceport Complex in Alaska, with completion slated for December 31, 2028. Of the total, $112 million comes from fiscal year 2025 research funds. The award emerged from a competitive bidding process involving three offers, carrying contract number FA8818-26-C-B003.
The launches will use the HASTE rocket, a test platform derived from Rocket Lab’s Electron — now the second-most-launched US rocket, having deployed 262 satellites to date. The deal comes hot on the heels of Rocket Lab’s selection for the National Security Space Launch Phase 3 Lane 1 program, a $17 billion umbrella contract for future launch services shared with SpaceX and five other companies.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
From Overbought to Oversold
The contract news arrives during a brutal stretch for the stock. From its all-time high of $151 in late May, Rocket Lab had cratered nearly 45% — and the 30-day decline alone exceeded 31%. The 14-day relative strength index had sunk to 33.3, deep in oversold territory, suggesting the selling had become overdone.
The broader sector sell-off had multiple triggers. Blue Origin’s New Glenn rocket exploded during a test in early June, rattling investor confidence across the space complex. Rumors of a lower valuation for SpaceX’s upcoming IPO added to the gloom. Rocket Lab lost more than 15% in a single session during that rout. Insider selling added further pressure: over the past three months, company insiders unloaded $362.8 million worth of shares with zero purchases, a signal that retail traders found hard to ignore.
Wall Street Stays the Course
Despite the volatility, the analyst community remains largely constructive. The consensus from 22 analysts is “Moderate Buy,” with an average price target of $110.18 — implying roughly 59% upside from recent levels. Citizens analyst Trevor Walsh raised his target from $95 to $130, maintaining an “Outperform” rating, citing the planned acquisition of Iridium Communications as a catalyst for expanding into higher-value space applications.
Morgan Stanley went further, lifting its bull-case target from $185 to $293, with a base case of $105 and an “Overweight” rating. The bank’s rationale: Rocket Lab is beginning to look like a smaller version of SpaceX. Not everyone is convinced. Piper Sandler initiated coverage in July with a neutral stance, arguing the valuation remains ambitious despite the growing defense contract backlog.
The Numbers Tell Two Stories
The valuation metrics are a study in extremes. The price-to-sales ratio stands at 56.72, while the price-to-book ratio hits 18.99 — both reflecting the enormous growth expectations baked into the stock. The company remains unprofitable, with a loss per share of $0.33 and a beta of 2.54, meaning it moves more than two and a half times as much as the broader market on any given day. A proprietary scoring model gives Rocket Lab 71 out of 100, with strong marks for financial strength but weak scores on profitability.
Rocket Lab USA at a turning point? This analysis reveals what investors need to know now.
Yet the operational trajectory is unmistakable. First-quarter 2026 revenue topped $200 million, up 63% year-over-year, with a record backlog of $2.2 billion. More launch contracts were signed in that single quarter than in all of 2025. The Iridium acquisition, if completed, would create a seamless end-to-end space services provider — from launch to satellite operations.
The Neutron Factor
Beyond the immediate defense wins, investors are watching the Neutron rocket program. Designed to lift 13 metric tons to orbit, Neutron represents Rocket Lab’s bid to move beyond the small-launch niche. Progress on engine tests and subsystem validation will determine whether the company can credibly scale its business model. The first Neutron launch is targeted for the fourth quarter of 2026.
For now, the combination of a sector-wide recovery and a fresh Space Force contract has shifted the narrative away from short-term price swings and toward the growing defense and security order book. But the violent oscillations of the past month serve as a reminder: this is a stock that moves on sentiment as much as fundamentals, and the gap from current levels to the $151 record high remains more than 54%.
Ad
Rocket Lab USA Stock: New Analysis - 22 July
Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
